{"id":"https://openalex.org/W2005371966","doi":"https://doi.org/10.1046/j.1365-2680.1998.1830167.x","title":"Ryanodine\u2010 and cyclopiazonic acid\u2010sensitive components in human vas deferens contractions to noradrenaline","display_name":"Ryanodine\u2010 and cyclopiazonic acid\u2010sensitive components in human vas deferens contractions to noradrenaline","alternate_titles":[],"publication_year":1998,"publication_date":"1998-06-01","ids":{"openalex":"https://openalex.org/W2005371966","doi":"https://doi.org/10.1046/j.1365-2680.1998.1830167.x","mag":"2005371966","pmid":"https://pubmed.ncbi.nlm.nih.gov/9754637"},"language":"en","primary_location":{"id":"doi:10.1046/j.1365-2680.1998.1830167.x","doi":"https://doi.org/10.1046/j.1365-2680.1998.1830167.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1365-2680.1998.1830167.x","pdf_url":null,"source":{"id":"https://openalex.org/S103683400","display_name":"Journal of Autonomic Pharmacology","issn_l":"0144-1795","issn":["0144-1795","1365-2680"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Autonomic Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2005371966"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035366642","display_name":"Nnaemeka I. B. Amobi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"N. I. B. Amobi","raw_affiliation_strings":["Biomedical Sciences Division, King's College London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biomedical Sciences Division, King's College London, UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112034177","display_name":"I. C. H. Smith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"I. C. H. Smith","raw_affiliation_strings":["Biomedical Sciences Division, King's College London, Campden Hill Road, London W8 7AH, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biomedical Sciences Division, King's College London, Campden Hill Road, London W8 7AH, UK","institution_ids":["https://openalex.org/I183935753"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5112034177"],"corresponding_institution_ids":["https://openalex.org/I183935753"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"18","issue":"3","first_page":"167","last_page":"176"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10493","display_name":"Ion channel regulation and function","score":0.951200008392334,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10493","display_name":"Ion channel regulation and function","score":0.951200008392334,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13415","display_name":"Calcium signaling and nucleotide metabolism","score":0.015399999916553497,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11204","display_name":"Ion Channels and Receptors","score":0.014100000262260437,"subfield":{"id":"https://openalex.org/subfields/2809","display_name":"Sensory Systems"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vas-deferens","display_name":"vas deferens","score":0.8169999718666077},{"id":"https://openalex.org/keywords/norepinephrine","display_name":"norepinephrine","score":0.8669999837875366},{"id":"https://openalex.org/keywords/ryanodine","display_name":"ryanodine","score":0.7319999933242798},{"id":"https://openalex.org/keywords/cyclopiazonic-acid","display_name":"cyclopiazonic acid","score":1.0},{"id":"https://openalex.org/keywords/intracellular-calcium-stores","display_name":"intracellular calcium stores","score":0.7450000047683716},{"id":"https://openalex.org/keywords/caffeine","display_name":"caffeine","score":0.6650000214576721},{"id":"https://openalex.org/keywords/nifedipine","display_name":"nifedipine","score":0.8740000128746033},{"id":"https://openalex.org/keywords/intracellular-calcium","display_name":"intracellular calcium","score":0.7279999852180481},{"id":"https://openalex.org/keywords/ryanodine-receptor","display_name":"ryanodine receptor","score":0.7919999957084656},{"id":"https://openalex.org/keywords/sarcoplasmic-reticulum-ca2-atpase","display_name":"sarcoplasmic reticulum Ca2+-ATPase","score":0.9150000214576721},{"id":"https://openalex.org/keywords/smooth-muscle-contraction","display_name":"smooth muscle contraction","score":0.7860000133514404},{"id":"https://openalex.org/keywords/longitudinal-muscle","display_name":"longitudinal muscle","score":0.6890000104904175},{"id":"https://openalex.org/keywords/circular-muscle","display_name":"circular muscle","score":0.9539999961853027}],"concepts":[{"id":"https://openalex.org/C113217602","wikidata":"https://www.wikidata.org/wiki/Q416781","display_name":"Ryanodine receptor","level":3,"score":0.8956561088562012},{"id":"https://openalex.org/C2778500429","wikidata":"https://www.wikidata.org/wiki/Q60235","display_name":"Caffeine","level":2,"score":0.8153815269470215},{"id":"https://openalex.org/C2779996123","wikidata":"https://www.wikidata.org/wiki/Q5198954","display_name":"Cyclopiazonic acid","level":3,"score":0.7822647094726562},{"id":"https://openalex.org/C2776050358","wikidata":"https://www.wikidata.org/wiki/Q127006","display_name":"Muscle contraction","level":2,"score":0.6561387777328491},{"id":"https://openalex.org/C519063684","wikidata":"https://www.wikidata.org/wiki/Q706","display_name":"Calcium","level":2,"score":0.6514464616775513},{"id":"https://openalex.org/C2779066535","wikidata":"https://www.wikidata.org/wiki/Q39111","display_name":"Nifedipine","level":3,"score":0.6470887660980225},{"id":"https://openalex.org/C163415756","wikidata":"https://www.wikidata.org/wiki/Q126473","display_name":"Contraction (grammar)","level":2,"score":0.6337764263153076},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.576797366142273},{"id":"https://openalex.org/C2777658833","wikidata":"https://www.wikidata.org/wiki/Q408437","display_name":"EGTA","level":3,"score":0.5381428003311157},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5170917510986328},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4815090596675873},{"id":"https://openalex.org/C2778210472","wikidata":"https://www.wikidata.org/wiki/Q735505","display_name":"Vas deferens","level":2,"score":0.46082720160484314},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2966870665550232},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.23905274271965027}],"mesh":[{"descriptor_ui":"D000252","descriptor_name":"Calcium-Transporting ATPases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D000316","descriptor_name":"Adrenergic alpha-Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002110","descriptor_name":"Caffeine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002121","descriptor_name":"Calcium Channel Blockers","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009119","descriptor_name":"Muscle Contraction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009543","descriptor_name":"Nifedipine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009638","descriptor_name":"Norepinephrine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D012433","descriptor_name":"Ryanodine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014649","descriptor_name":"Vas Deferens","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D014649","descriptor_name":"Vas Deferens","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1046/j.1365-2680.1998.1830167.x","doi":"https://doi.org/10.1046/j.1365-2680.1998.1830167.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1365-2680.1998.1830167.x","pdf_url":null,"source":{"id":"https://openalex.org/S103683400","display_name":"Journal of Autonomic Pharmacology","issn_l":"0144-1795","issn":["0144-1795","1365-2680"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Autonomic Pharmacology","raw_type":"journal-article"},{"id":"pmid:9754637","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9754637","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of autonomic pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.6240000128746033,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320311904","display_name":"Wellcome Trust","ror":"https://ror.org/029chgv08"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":65,"referenced_works":["https://openalex.org/W72476091","https://openalex.org/W206588626","https://openalex.org/W1525421301","https://openalex.org/W1528829697","https://openalex.org/W1546706272","https://openalex.org/W1853779907","https://openalex.org/W1884189199","https://openalex.org/W1930097492","https://openalex.org/W1968390509","https://openalex.org/W1971936465","https://openalex.org/W1973158090","https://openalex.org/W1974903792","https://openalex.org/W1975700762","https://openalex.org/W1975827500","https://openalex.org/W1977759935","https://openalex.org/W1979632046","https://openalex.org/W1979700096","https://openalex.org/W1984234875","https://openalex.org/W1988599640","https://openalex.org/W1994358269","https://openalex.org/W1994950241","https://openalex.org/W1995279363","https://openalex.org/W2001044508","https://openalex.org/W2001558241","https://openalex.org/W2007588524","https://openalex.org/W2009087599","https://openalex.org/W2009346801","https://openalex.org/W2013023765","https://openalex.org/W2014346297","https://openalex.org/W2022398918","https://openalex.org/W2022997659","https://openalex.org/W2024378782","https://openalex.org/W2025147909","https://openalex.org/W2026202296","https://openalex.org/W2032467525","https://openalex.org/W2036783689","https://openalex.org/W2050389355","https://openalex.org/W2059794282","https://openalex.org/W2067449150","https://openalex.org/W2083498516","https://openalex.org/W2085276868","https://openalex.org/W2085947939","https://openalex.org/W2086166706","https://openalex.org/W2087284134","https://openalex.org/W2090851695","https://openalex.org/W2092224962","https://openalex.org/W2092340359","https://openalex.org/W2096900775","https://openalex.org/W2100738182","https://openalex.org/W2107308340","https://openalex.org/W2112881946","https://openalex.org/W2116243720","https://openalex.org/W2117740148","https://openalex.org/W2119287922","https://openalex.org/W2119362774","https://openalex.org/W2130235293","https://openalex.org/W2143565170","https://openalex.org/W2150361967","https://openalex.org/W2160164901","https://openalex.org/W2249214832","https://openalex.org/W2261652666","https://openalex.org/W2269015094","https://openalex.org/W2395534010","https://openalex.org/W2408987204","https://openalex.org/W2435467685"],"related_works":["https://openalex.org/W1983457511","https://openalex.org/W46066015","https://openalex.org/W2027968883","https://openalex.org/W2029881352","https://openalex.org/W2095418206","https://openalex.org/W2050607639","https://openalex.org/W2014109682","https://openalex.org/W2088634197","https://openalex.org/W2067449150","https://openalex.org/W2129603010"],"abstract_inverted_index":{"1.":[0],"The":[1,120,175,296],"role":[2],"of":[3,12,27,50,78,88,98,106,122,134,143,177,191,203,211,241,251,274,300,310],"calcium":[4,29,252],"stores":[5],"in":[6,24,35,149,165,172,196,206,215],"noradrenaline-":[7],"(NA)":[8],"and":[9,20,53,81,109,138,237,260,279,292,313],"caffeine-induced":[10],"contractions":[11,49,77,117,164,214],"human":[13],"vas":[14],"deferens":[15],"were":[16,219],"investigated":[17],"using":[18],"ryanodine":[19,123,178,224],"cyclopiazonic":[21],"acid":[22],"(CPA)":[23],"the":[25,28,82,96,110,127,132,135,140,144,192,201,238,271,311],"presence":[26,97,121,176,202],"antagonist,":[30],"nifedipine":[31,204],"(1":[32,37],"microM)":[33,46,71,75],"or":[34,72,124,179,205,225],"calcium-free/EGTA":[36],"mM)":[38,60],"medium.":[39],"2.":[40],"In":[41,95,153,200,267],"either":[42,189,223],"media,":[43,155,208],"NA":[44,148,236,245,278],"(100":[45],"evoked":[47,61,213],"biphasic":[48],"longitudinal":[51,62,89,115,150,173,197,216,242,268],"muscle":[52,56,66,90,116,217,233,243,302],"tonic":[54],"circular":[55,65,79,107,166,232,301],"contractions.":[57,67],"Caffeine":[58],"(20":[59],"but":[63,84,112,168,288],"not":[64,85,113,220],"3.":[68],"Ryanodine":[69],"(1-30":[70,74],"CPA":[73,125,180],"inhibited":[76],"muscle,":[80,108,167,269],"initial":[83,111,136,239],"secondary":[86,114,141,272],"component":[87,137,142,190,240,273],"contraction":[91,195,234,280],"to":[92,101,118,147,244,277,281,284,298],"NA.":[93,119],"4.":[94],"nifedipine,":[99],"pre-exposure":[100],"caffeine":[102,128,156,182,212,282,299],"caused":[103,305],"a":[104,257,263,307],"potentiation":[105,133],"during":[126,181],"pre-exposures":[129,157,183],"effectively":[130],"blocked":[131,221],"reduced":[139,169],"subsequent":[145,162,193],"responses":[146],"muscle.":[151,174,198],"5.":[152],"calcium-free":[154,207],"had":[158],"little":[159],"effect":[160],"on":[161,188],"NA-induced":[163,194],"both":[170,246,270],"components":[171],"produced":[184],"no":[185],"further":[186],"effects":[187],"6":[199],"repeated":[209],"applications":[210],"which":[218],"by":[222,235,306],"CPA.":[226],"7.":[227],"These":[228],"results":[229],"suggest":[230],"that":[231,253],"utilize":[247],"an":[248,286],"intracellular":[249],"pool":[250],"is":[254],"triggered":[255],"via":[256,262],"ryanodine-sensitive":[258],"mechanism":[259],"replenished":[261],"CPA-sensitive":[264],"Ca2+-ATPase.":[265],"8.":[266],"its":[275],"response":[276],"appear":[283],"involve":[285],"unusual":[287],"pharmacologically":[289],"distinct":[290],"(ryanodine-":[291],"CPA-insensitive)":[293],"pathway.":[294,315],"9.":[295],"quiescence":[297],"may":[303],"be":[304],"relative":[308],"absence":[309],"ryanodine-":[312],"CPA-insensitive":[314]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2005371966","counts_by_year":[],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
